Expanded Access to ABC-108, A Phase IIA Study of ABC294640 in the Treatment of Patients With Advanced,Unresectable Intra-hepatic, Perihilar and Extra-Hepatic Cholangiocarcinoma
Latest Information Update: 17 Sep 2018
At a glance
- Drugs Opaganib (Primary)
- Indications Cholangiocarcinoma; Gallbladder cancer
- Focus Expanded access; Therapeutic Use
- Sponsors RedHill Biopharma
- 06 Sep 2018 Results of a single patients with advanced gallbladder carcinoma presented in the RedHill Biopharma Media Release
- 01 Feb 2018 New trial record